Want to join the conversation?
$AMGN entered into a definitive agreement to acquire a Netherlands-based biotechnology company, Dezima Pharma, that could be worth as much as $1.35Bil if a certain threshold is reached. Dezima shareholders have approved the agreement. Following the completion of the transaction, Dezima Pharma will become a wholly-owned subsidiary of $AMGN.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.